Proximal Ventures raises debut fund to back startups bringing AI to drug development
Tuesday, November 10, 2026 · first reported by TechCrunch
Sahir Raoof, who previously invested at SignalFire, has closed a $27.5 million first fund under his new firm, Proximal Ventures. The fund targets pre-seed and seed-stage startups applying AI to the tools, infrastructure and services behind drug development, with cheques of $500,000 to $1.5 million.
Six companies are already in the portfolio. One is ChronicleBio, whose co-founders include Fidji Simo, formerly an OpenAI executive. Investors in the fund include SignalFire, Kleiner Perkins, Bertelsmann Healthcare Investments, Nan Li, Zavain Dar and Amy Abernethy.
- Fund
- Proximal Ventures debut fund
- Size
- $27.5M
- Stage
- Launch
- People
- Sahir Raoof
- Asset class
- Venture
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
Coverage
1 source- OpenAI Backer Altimeter Targets More Than $3 Billion for Private Markets FundsBloomberg
- Raft of secondaries funds contribute to StepStone’s ~$11bn raise for new vintagesPEI Secondaries Investor
- Redalpine closes oversubscribed $250m eighth early-stage fund with backing from Aviva, KfWAltAssets +1
- PSA International and Granite Asia Launch US$50 Million Fund to Scale Global Supply Chain TechnologyLM - Logistics Manager
- Cuatrecasas advises 33N Ventures on the launch of a €200 million fund for AI, cybersecurity and defense technologyLíder Legal
- Noctua Science Ventures achieves €15m first closeThe Next Leap »
Got news? Send it to us →